[1]黄帆,高阳,张玉民,等.新型渗透性水凝胶作为载体用于肿瘤的放射性核素植入治疗[J].国际放射医学核医学杂志,2017,41(2):81-87.[doi:10.3760/cma.j.issn.1673-4114.2017.02.001]
　Huang Fan,Gao Yang,Zhang Yumin,et al.New permeable hydrogel for tumor radiotherapy in situ[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(2):81-87.[doi:10.3760/cma.j.issn.1673-4114.2017.02.001]
点击复制

新型渗透性水凝胶作为载体用于肿瘤的放射性核素植入治疗(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
41
期数:
2017年第2期
页码:
81-87
栏目:
论著
出版日期:
2017-03-25

文章信息/Info

Title:
New permeable hydrogel for tumor radiotherapy in situ
作者:
黄帆;  高阳;  张玉民;  杨丽军;  褚丽萍;  刘金剑
300192 天津, 中国医学科学院放射医学研究所, 天津市放射医学与分子核医学重点实验室
Author(s):
Huang Fan;  Gao Yang;  Zhang Yumin;  Yang Lijun;  Chu Liping;  Liu Jinjian
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science, Tianjin 300192, China
关键词:
肿瘤; 水凝胶; 放射性同位素; 近距离放射疗法
Keywords:
Neoplasms; Hydrogel; Radioisotopes; Brachytherapy
DOI:
10.3760/cma.j.issn.1673-4114.2017.02.001
摘要:
目的 设计并合成一类新型的渗透性水凝胶，通过物理作用负载放疗剂，用于肿瘤的植入治疗。方法 通过酯化反应合成聚合物PECT-RGD（其中，PECT为含环醚侧基聚己内酯-聚乙二醇三嵌段共聚物；RGD为含有精氨酸-甘氨酸-天冬氨酸的短肽），通过酰胺化反应和氯胺T法制备131I标记的透明质酸，核磁共振氢谱（1H-NMR）对其化学结构进行表征；沉淀离心纯化法对标记的透明质酸进行分离纯化；小瓶翻转法验证凝胶的形成；MTT法研究聚合物材料的细胞毒性；利用放射性小动物活体成像系统研究小鼠体内植入的凝胶的体内稳定性及降解情况；通过抑制肿瘤生长体积和肿瘤组织切片研究131I@PECT-RGD凝胶的体内抗肿瘤效率。结果 聚合物PECT-RGD没有细胞毒性；在正常生理体温（37℃）下能够形成稳定的凝胶，并且可以在体内发生自降解；与PBS组相比，注射131I@PECT-RGD凝胶组和131I@PECT凝胶组均呈现较高的抗肿瘤效率，与PBS组比较差异有统计学意义（F=71.968，P<0.05）；131I@PECT-RGD凝胶组与131I@PECT凝胶组比较，抗肿瘤效率之间的差异也具有统计学意义（t=7.276，P<0.05）；3组小鼠体重差异无统计学意义（F=3.878，P>0.05）；HE染色结果显示，注射PBS组的肿瘤组织仅出现小部分坏死，注射131I@PECT凝胶组的肿瘤组织大部分坏死，注射131I@PECT-RGD凝胶组的肿瘤组织基本坏死。结论 131I@PECT-RGD凝胶能够原位注射到肿瘤组织，具有良好的生物相容性、自降解性和抗肿瘤效果，是一种非常有应用前景的肿瘤局部放疗方法。
Abstract:
Objective To design and synthesize a novel permeable hydrogel loaded with a radiation agent for the implantation radiotherapy of tumors. Methods The polymer PECT-RGD[PECT:poly(ε-caprolactone-co-1,4,8-trioxa[4.6]spiro-9-undecanone)-poly(ethylene glycol)-poly(ε-caprolactone-co-1,4,8-trioxa[4.6]spiro-9-undecanone); RGD:Arg-Gly-Asp] was synthesized by esterification reaction, and an 131I-labeled hyaluronic acid was prepared by amidation reaction and chloramine-T method. The chemical structure of them was characterized by 1H-NMR, and the 131I-labeled hyaluronic acid was isolated and purified by precipitation and centrifugation. Hydrogel formation was verified by vial flipping experiment, and the cytotoxicity of the polymer materials was evaluated by MTT assay. The in vivo stability and degradation of the injected hydrogel were studied using a radioactive small animal live imaging system. The in vivo antitumor effect of the 131I@PECT-RGD hydrogel was investigated by inhibiting tumor growth volume and tumor tissue section. Results The polymer PECT-RGD was non-cytotoxic and could form a stable hydrogel under the normal physiological temperature(37℃). This hydrogel is capable of self-degradation in vivo. Compared with the PBS group, the 131I@PECT-RGD hydrogel and the 131I@PECT gel showed significantly higher anti-tumor efficiency (P<0.05, F=71.968). A significant difference in anti-tumor efficiency was found between the 131I@PECT and 131I@PECT-RGD hydrogels (P<0.05, t=7.276). No significant difference in body weight was found among the three groups (P>0.05, F=3.878). HE staining showed that only a small part of the tumor tissue was necrotic in the PBS group, whereas a large part of the tumor tissue was necrotic in the 131I@PECT group; the tumor tissue of the 131I@PECT-RGD group was generally necrotic. Conclusions The 131I@PECT-RGD hydrogel could be injected into tumor tissue in situ and display great biocompatibility, self-degradation ability, and anti-tumor activity. Thus, this hydrogel has potential applications in local radiotherapy.

参考文献/References:

[1] De MO, Vakaet LL, De GT, et al. Radiotherapy of prostate cancer with or without intensity modulated beams:a planning comparison[J]. Int J Radiat Oncol Biol Phys, 2000, 47(3):639-648.
[2] Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation[J]. Nat Rev Drug Discov, 2013, 12(7):526-542. DOI:10. 1038/nrd4003.
[3] Bentzen SM. Preventing or reducing late side effects of radiation therapy:radiobiology meets molecular pathology[J]. Nat Rev Cancer, 2006, 6(9):702-713..
[4] 李功祥, 李险峰. 放化疗相关性肺损伤的研究进展[J]. 国际放射医学核医学杂志, 2010, 34(4):237-241. DOI:10. 3760/cma. j. issn. 1673-4114. 2010. 04. 013. Li GX, Li XF. Proress research on of chemoradiotherapy-ralated lung injury[J]. Int J Radiat Med Nucl Med, 2010, 34(4):237-241.
[5] 张淼. 新型碘125籽源核芯的设计与制备研究[D]. 合肥:中国科学技术大学, 2016:6-16. Zhang M. Design and fabrication of new 125I brachytherapy source[D]. Hefei:University of Science and Technology of China, 2016:6-16.
[6] 朱晓珉, 方文岩, 陈军, 等. CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J]. 国际放射医学核医学杂志, 2011, 35(2):114-117. DOI:10. 3760/cma. j. issn. 1673-4114. 2011. 02. 012. Zhu XM, Fang WY, Chen J, et al. CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J]. Int J Radiat Med Nucl Med, 2011, 35(2):114-117.
[7] Zhang Y, Yang C, Wang W, et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer[J/OL]. Sci Rep, 2016, 6:21225[2017-01-19]. https://www.ncbi.nlm.nih.gov/pubmed/26876480. DOI:10. 1038/srep21225.
[8] Wang W, Deng L, Liu S, et al. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol) co-polymer[J]. Acta Biomater, 2012, 8(11):3963-3973. DOI:10. 1016/j. actbio. 2012. 07. 021.
[9] Huang P, Zhang Y, Wang W, et al. Co-delivery of doxorubicin and 131I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy[J]. J Control Release, 2015, 220(Pt A):456-464. DOI:10. 1016/j. jconrel. 2015. 11. 007.
[10] Wang WW, Deng LD, Xu SX, et al. A reconstituted "two into one" thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymer nanoparticles for the local delivery of paclitaxel[J]. J Mater Chem B, 2013, 1(4):552-563. DOI:10. 1039/c2tb00068g.
[11] Dhar S, Gu FX, Langer R, et al. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles[J]. Proc Natl Acad Sci U S A, 2008, 105(45):17356-17361. DOI:10. 1073/pnas. 0809154105.
[12] Wu J, Zheng Z, Li G, et al. Control of silk microsphere formation using polyethylene glycol(PEG)[J/OL]. Acta Biomater, 2016, 39:156-168[2017-01-19]. http://www.sciencedirect.com/science/article/pii/S1742706116302379. DOI:10. 1016/j. actbio. 2016. 05. 019.
[13] Gong C, Shi S, Dong P, et al. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel[J]. Int J Pharm, 2009, 365(1/2):89-99. DOI:10. 1016/j. ijpharm. 2008. 08. 027.
[14] Liu J, Deng H, Liu Q, et al. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo[J]. Nanoscale, 2015, 7(10):4451-4460. DOI:10. 1039/c4nr07435a.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
　Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
　Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
　zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
　Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
　Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
　Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
　Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
　Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]

备注/Memo

备注/Memo:
收稿日期:2017-01-20。
基金项目:国家自然科学基金（51603231）；中国医学科学院与健康科技创新工程项目（2016-I2M-3-022）；天津市自然科学基金（16JCQNJC02500）；“协和青年基金资助”和“中央高校基本科研业务费专项资金资助”（3332016098）；中国医学科学院、北京协和医学院“中央级公益性科研院所基本科研业务费”（2016ZX310079）
通讯作者:刘金剑,Email:liujinjian2002@163.com
更新日期/Last Update: 2017-04-24